Thompson Scott M, Schmitz John J, Schmit Grant D, Callstrom Matthew R, Kurup Anil Nicholas
Department of Radiology, Mayo Clinic School of Medicine, 200 1st St SW, Rochester, MN, 55905, USA.
Curr Treat Options Oncol. 2017 Apr;18(4):25. doi: 10.1007/s11864-017-0465-1.
Percutaneous thermal ablation, including microwave ablation (MWA), radiofrequency ablation (RFA), and cryoablation, is a well-established focal treatment option for primary and metastatic malignancies. While published literature specific to ablation of sarcomas is relatively lacking compared with non-sarcomatous malignancies, what is available is promising. In situations where a focal treatment option is desired, strong consideration should be given to percutaneous thermal ablation, in addition to surgery and radiation therapy. A significant advantage of percutaneous thermal ablation over surgery and radiation includes the repeatability of ablation, as there is no absolute limit on the number of times an ablation can be performed. Compared with surgery, ablation offers the potential of decreased recovery time, a less invasive procedure, and is often performed in patients deemed not medically fit for surgery.
经皮热消融,包括微波消融(MWA)、射频消融(RFA)和冷冻消融,是一种成熟的针对原发性和转移性恶性肿瘤的局部治疗选择。与非肉瘤性恶性肿瘤相比,关于肉瘤消融的已发表文献相对较少,但现有文献显示前景良好。在希望采用局部治疗方案的情况下,除手术和放射治疗外,应充分考虑经皮热消融。经皮热消融相对于手术和放射治疗的一个显著优势是消融的可重复性,因为消融次数没有绝对限制。与手术相比,消融具有恢复时间可能缩短、侵入性较小的特点,并且通常适用于被认为不适合手术的患者。